Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$72.8M
3 rounds on record
Latest round
$21.8M
Venture round · May 2024 · 2 yr ago
Team
53
US Form 5500 (plan participants) · Dec 2024
Backers
1
Westlake BioPartners
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 17, 2024 Raised a round Venture round $21.8M · SEC Form D Aug 31, 2021 Raised a round Venture round $35M · SEC Form D Feb 5, 2021 Raised a round Venture round $16M · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2024 $21.8M — SEC Form D
Venture round Aug 2021 $35M — SEC Form D
Venture round Feb 2021 $16M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Kate Therapeutics Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Kevin Forrest Ph.D.Executive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1

People

Kevin Forrest Ph.D.
Executive Officer, Director
Clare Ozawa Ph.D.
Director
Beth Seidenberg M.D.
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego United States
HQ
200-500 est. staff

Financials

Total raised
$72.8M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $21.8M Details
Venture - Series Unknown 2021 $35M Details
Venture - Series Unknown 2021 $16M Details